Obesity clinical trials
Showing 551–600 of 714 active trials. Describe your situation to see which ones you may be eligible for.
- Trial of the Combination of Alpha-Lipoic Acid and Mirabegron in Women and in Men With Obesity
- Fuzzle System for Appetite Control and Weight Management
- Brain Plasticity and GLP-1 Receptor Agonist Treatment for Obesity
- VITAL-IMPACT: Improving Cardiometabolic Health in Black Individuals Through Therapeutic Augmentation of Cyclic Guanosine Mono-Phosphate Signaling Pathway
- Combatting Muscle Loss in Obese Adult Patients on GLP-1 Medications Through Dietary Counseling and Exercise During Treatment Evaluates Whether a 12-week Exercise and Individualized Nutrition Program Can Reduce Muscle and Bone Loss and Improve Strength, Fitness, and Function in Obese Adults on GLP-1
- Small Changes Clinical Weight Loss Trial
- Improving Health Among Disadvantaged Girls to Slow Pubertal Onset and Reduce Long-term Health Risks
- A Multiple Health Behavior Change (MHBC) Intervention for Weight Loss and Smoking Cessation for Pre-Bariatric Surgery Patients
- Comparison of AirSeal to DV5 Insufflation in Gastric Sleeve Procedures - The "CAT5-GS" Study
- AMAZE 8: A Research Study Investigating How Well the Medicine NNC0487-0111 Compared to Semaglutide Helps People With Excess Body Weight and Type 2 Diabetes Lose Weight
- "F!reF!ghterF!t": Lifestyle Coaching Interventions for Obese Firefighters (FireFit)
- Augmenting Primary Care-Based Obesity Management With the Nutu™ Digital Health Platform
- Continuous Glucose Monitoring in Metabolic Surgery
- Partnership to Reduce Obesity in Community Health Center Patients (SMARTLife Utah)
- Digitally Enhanced Cognitive-Behavioral Therapy
- Evaluation of a Mobile Wellness Application and Wearable Fitness Tracker on Weight Management and Health Outcomes
- MODERN-Dental: Pediatric Obesity, Cardiometabolic Risks, And Periodontal Disease
- Impact of a Produce Prescription Program and Nutrition Education Intervention on Cardiovascular Health in Youth
- Inhaled Nitric Oxide in Severe Obesity
- Adiposity Distribution in Acute Respiratory Failure
- Switching to Oral Weight Management Pharmacotherapy to Prevent Weight Regain After GLP-1 Therapy Discontinuation
- Semaglutide for Low Back Pain
- A Study to Learn How Different Amounts of the Study Medicine Called PF-08642534 Are Tolerated and Act in the Body of People Who Have Obesity
- AMAZE 9: A Research Study Investigating How Well Zenagamtide Tablets Help People With Excess Body Weight Lose Weight
- Nutrition Intervention Optimization to Better Utilize Resources and Support Health
- Imaging in Semaglutide Study
- Assessing Follow up Trajectories in Eating, Routines, and Weight After GLP-1
- High-protein plUs reSistance Training in gLucagon-like pEptide 1 Receptor Agonist Users (HUSTLE)
- The Effects of Lumateperone on Obesity and Physiologic Aging and Their Association With Antidepressant Response in Bipolar Depression
- Interplay of Central and Peripheral Vascular Effects of Insulin in Obesity
- Glucagon-Like Peptide-1 Receptor Agonists to Attenuate Metabolic Risk in Individuals With Duchenne Muscular Dystrophy
- Validation of a Body-Composition Segmentation Software on a Diverse Public CT Scan Cohort
- GLP-1 Medication & Behavioral Health Programs on Weight & Metabolic Outcomes: FLOURISH and THRIVE Prospective Cohort Study
- A Natural History of Genetic and Environmental Predictors of Pubertal Timing Among Youth With Obesity
- A Study Comparing Continuous Glucose Monitoring Augmented Nutritional Counseling and Standard of Care Treatment Strategies in a Three-Month Nutrition Intervention
- Cardiometabolic Effects of the Recommended Daily Pecan Intake Dose
- Effect Of Whole or Skimmed Milk Greek Yogurt on Integrated Muscle Protein Synthesis, Glucose Homeostasis, and Cognition in Post-Menopausal Women
- Growth Hormone Resistance of Beta-cells
- Evaluation of the Clinical Spectrum of Diabetes and Obesity in Youth and Adults
- Assessing the Impact of Perceptions of Unpredictability on Objective Measures of Food Consumption and Metabolism
- The RISC Registry--Risk Informed Screening Registry
- A Study of VV-14303 for the Treatment of Metabolic Dysfunction-associated Steatohepatitis (MASH)
- Plasma Lipids-Dependent Vitamin E Metabolism During Dynamic Hyperlipidemia
- Periodontal Inflammation and Epigenetics in Obese Individuals
- Assess the Effects of Replacing Foods High in Refined Carbohydrates With Avocado on Biomarkers of Inflammation.
- AIManage Using an AI-driven CDS and Chatbot
- Gastric Ultrasound in Patients Who Have Undergone Bariatric Surgery
- Development of an Eating Behavior Risk Score
- Safety and Tolerability of a Nutritional Formula Designed to Aid in Maintenance of Muscle During Periods of Caloric Restriction in Adults
- Disulfiram in Rheumatoid Arthritis
Guides for people searching for a trial
- How to search for a trial without losing your mindWhere to look, what to gather first, and how to read what you find.
- Why people get turned down — and what to do nextWhat eligibility criteria are for, what keeps people out, and where to go when the first door closes.
- How your biomarkers decide which trials you qualify forEGFR, HER2, BRAF, PD-L1 and the rest — what they are and why they increasingly gate access.
- What Phase 1, 2 and 3 actually mean for youWhat each phase is testing, and how to weigh an early-phase trial against a later one.
- 10 questions to ask before you say yesTreatment, time, cost, safety and your rights. Worth bringing to a screening visit.
- You matched with a trial. What happens now?Phone screens, the screening visit, informed consent, and day one.